ALLARITY
LIVE

Serial Number

88962360

Owner

Oncology Venture A/S

Attorney

Richard Todd Armstrong

First Use Date

Oct 9, 2020

Filing Date

Jun 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ALLARITY Trademark

Serial Number: 88962360 • Registration: 7882690

ALLARITY is a trademark filed by Oncology Venture A/S on June 12, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Oncology Venture A/S (4 trademarks)

Venlighedsvej 1
Hørsholm 2970 , DK

Entity Type: 03

ALLARITY THERAPEUTICS, INC. (3 trademarks)

CAMBRIDGE, MA 02139

Entity Type: 03

Trademark Details

Filing Date

June 12, 2020

Registration Date

August 5, 2025

First Use Anywhere

October 9, 2020

First Use in Commerce

October 9, 2020

Published for Opposition

July 27, 2021

Goods & Services

Pharmaceuticals and pharmaceutical preparations for the treatment of cancer

Medical services in the field of cancer; Medical diagnostic testing, monitoring and reporting services in the field of cancer; Medical testing for diagnostic or treatment purposes in the field of cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 17, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 17, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2025 CRFA
ASSIGNED TO LIE
Jun 16, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 28, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 28, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Feb 28, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 4, 2025 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Jan 31, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2025 AITU
USE AMENDMENT FILED
Nov 15, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 15, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2024 EXRA
SOU EXTENSION 5 GRANTED
Jul 10, 2024 EX5G
SOU EXTENSION 5 FILED
Jul 10, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 10, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jan 17, 2024 EX4G
SOU EXTENSION 4 FILED
Jan 17, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 17, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 6, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 6, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 6, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 4, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 4, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 4, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jun 23, 2022 EX1G
SOU EXTENSION 1 FILED
Jun 23, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 23, 2022 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 19, 2022 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 18, 2022 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 5, 2021 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 28, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2021 CNSA
DATA MODIFICATION COMPLETED
Jun 22, 2021 DMCC
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2021 CRFA
ASSIGNED TO LIE
Jun 10, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2020 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2020 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2020 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 9, 2020 NWOS